@ASCO presented by @MyMKaiser ➡️ Dara-CVRD for Ultra High Risk #myeloma and Plasmacell leukemia induces deep remissions ➡️but still with shorter PFS #ASCO21 #mmsm pic.twitter.com/mkkFPNwpdi

— Suzanne Lentzsch, MD, PhD (@SLentzsch) June 8, 2021